Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
SMARCAL1 mutations that cause Schimke immunoosseous dysplasia or that inactivate the HARP2 domain abrogate these activities.
|
22279047 |
2012 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
For SMARCAL1 mutations a clear genotype-phenotype correlation has been reported: severe SIOD with in utero or early-childhood onset leading to end-stage renal disease within a few years is caused by nonsense, frame shift or splice mutations.
|
16237566 |
2005 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient.
|
24197801 |
2014 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SMARCAL1 are associated with the disease Schimke immuno-osseous dysplasia, a multisystem autosomal recessive disorder characterized by T cell immunodeficiency, growth inhibition, and renal dysfunction.
|
19841479 |
2009 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Analysis of mutant HARP proteins suggests that SIOD is caused by a deficiency in annealing helicase activity.
|
18974355 |
2008 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Here we report the identification of a new DNA damage response protein, SMARCAL1 (SWI/SNF-related, matrix associated, actin-dependent regulator of chromatin, subfamily a-like 1), which is a member of the SNF2 family and is mutated in Schimke immunoosseous dysplasia (SIOD).
|
19793862 |
2009 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia.
|
11799392 |
2002 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Recently, mutations of SMARCAL1, which encodes a putative chromatin remodelling protein, have been associated with SIOD.
|
15880370 |
2005 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, it illustrates the need to broaden the search for SMARCAL1 mutations in patients with SIOD lacking coding sequence variants.
|
25943327 |
2015 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In addition, previous reported SIOD cases showed excessive enrichment for mutations in the helicase ATP-binding and C-terminal domains of SMARCAL1.
|
31275356 |
2019 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel SMARCAL1 missense mutation that affects splicing in a severely affected Schimke immunoosseous dysplasia patient.
|
27282802 |
2016 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Described for the first time in 1971, Schimke immuno-osseous dysplasia (SIOD) is an autosomal-recessive multisystem disorder that is caused by bi-allelic mutations of SMARCAL1, which encodes a DNA annealing helicase.
|
22699664 |
2012 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
SIOD is caused by mutations in the gene SMARCAL1.
|
24589093 |
2014 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Biallelic mutations in swi/snf-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 (SMARCAL1) are the only identified cause of SIOD, but approximately half of patients referred for molecular studies do not have detectable mutations in SMARCAL1.
|
20013129 |
2010 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We investigate the mechanistic nature of the Snf2 family protein HARP, mutations of which are responsible for Schimke immuno-osseous dysplasia.
|
28334870 |
2017 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report a child with SIOD and a novel S859P missense mutation in SMARCAL1 who developed undifferentiated carcinoma of the sinus.
|
23630135 |
2013 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Schimke immuno-osseous dysplasia (SIOD) is a pleiotropic disorder caused by mutations in the SWI/SNF2-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like-1 (SMARCAL1) gene, with multiple clinical features, notably end-stage renal disease.
|
25319549 |
2015 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Schimke immuno-osseous dysplasia (SIOD) is an autosomal recessive disorder caused by mutations in SMARCAL1.
|
26309238 |
2015 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Furthermore, SIOD patient fibroblasts reconstituted with SMARCAL1 exhibit faster cell cycle progression after S-phase arrest.
|
19793862 |
2009 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The results from these experiments demonstrate that mutations in human SMARCAL1 that result in loss in ATPase activity lead to increased replication stress and therefore possibly manifestation of SIOD.
|
26195148 |
2015 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Integrated multiplex ligation dependent probe amplification (MLPA) assays for the detection of alterations in the HEXB, GM2A and SMARCAL1 genes to support the diagnosis of Morbus Sandhoff, M. Tay-Sachs variant AB and Schimke immuno-osseous dysplasia in humans.
|
23010210 |
2013 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Schimke immuno-osseous dysplasia (SIOD) is a fatal autosomal recessive disorder caused by loss-of-function mutations in swi/snf-related matrix-associated actin-dependent regulator of chromatin, subfamily a-like 1 (SMARCAL1).
|
16840568 |
2007 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Schimke immuno-osseous dysplasia is a rare autosomal recessive disease resulting from biallelic SMARCAL1 mutations.
|
30635151 |
2019 |
Schimke immunoosseous dysplasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Chromatin changes in SMARCAL1 deficiency: A hypothesis for the gene expression alterations of Schimke immuno-osseous dysplasia.
|
27813696 |
2016 |